Stockreport

Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement [Yahoo! Finance]

Aprea Therapeutics, Inc.  (APRE) 
PDF DOYLESTOWN, Pa., March 30, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology co [Read more]